# China NMPA Product Recall - Maxillofacial surgical instruments (trade name: SYNTHES)

Source: https://www.globalkeysolutions.net/records/china_product_recall/synthes-gmbh/7fe0ed3f-a232-4f0a-80ef-df0a9e9f72ee/
Source feed: China

> China NMPA product recall for Maxillofacial surgical instruments (trade name: SYNTHES) by Synthes GmbH published February 15, 2015. Recall level: Level II. Johnson & Johnson (Shanghai) Medical Devices Co., Ltd., on behalf of manufacturer Synthes GmbH, init

---

## Details

- Record Type: CHINA_PRODUCT_RECALL
- Title: Johnson & Johnson (Shanghai) Medical Devices Co., Ltd. voluntarily recalls maxillofacial surgical instruments.
- Company Name: Synthes GmbH
- Publication Date: 2015-02-15
- Product Name: Maxillofacial surgical instruments (trade name: SYNTHES)
- Recall Level: Level II
- Recall Reason: The manufacturer reviewed the complaint records and found multiple fractures at the tip of the beak-shaped bending and cutting forceps used to lock the 2.0 mandibular bone plate in a specific batch when bending or cutting thicker plates. If a fracture occurs while using this non-conforming product in the operating room, a replacement bending or cutting tool will be required, potentially causing surgical delays.
- Discovering Company: Johnson & Johnson (Shanghai) Medical Devices Co., Ltd.
- Manufacturing Company: Synthes GmbH
- Summary: Johnson & Johnson (Shanghai) Medical Devices Co., Ltd., on behalf of manufacturer Synthes GmbH, initiated a voluntary Class II recall of specific maxillofacial surgical instruments, formally reported to the National Medical Products Administration (NMPA) on January 21, 2015. The recall addresses a product issue with the "beaked bending-cutting forceps" (Model 329.143, SYNTHES brand), which were found to fracture when used to bend or cut thicker mandibular bone plates. This deficiency, identified through complaint records, carries the risk of delaying surgical procedures should a replacement tool be needed during an operation. While the instrument is auxiliary and does not directly contact patients, the product's non-conformance posed an operational challenge, though no direct patient adverse events were reported. Under the NMPA's regulatory framework, a Class II recall indicates a remote probability of serious adverse health consequences. The required actions involve Johnson & Johnson notifying all affected distributors to immediately cease using the identified products and arrange for their return. All 41 units imported to China, encompassing those sold, consigned, and held as fixed assets, are to be either returned to the manufacturer or destroyed locally to prevent further use.

Company: https://www.globalkeysolutions.net/companies/synthes-gmbh/77a06946-ba7a-4bf2-916a-600eabfb0ce7/